Bridgeway Capital Management
GNMX icon

Bridgeway Capital Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bridgeway Capital Management’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-223,500
Closed -$44K – 1431
2019
Q1 		$44K Hold
223,500
– – ﹤0.01% 1316
2018
Q4 		$156K Hold
223,500
– – ﹤0.01% 1252
2018
Q3 		$275K Buy
+223,500
New +$250K ﹤0.01% 1267
2017
Q2 		– Sell
-187,500
Closed -$349K – 1498
2017
Q1 		$349K Hold
187,500
– – ﹤0.01% 1171
2016
Q4 		$971K Hold
187,500
– – 0.01% 833
2016
Q3 		$1.04M Buy
187,500
+30,000
+19% +$171K 0.02% 776
2016
Q2 		$874K Buy
157,500
+38,500
+32% +$202K 0.01% 829
2016
Q1 		$524K Hold
119,000
– – 0.01% 1027
2015
Q4 		$716K Hold
119,000
– – 0.01% 908
2015
Q3 		$931K Hold
119,000
– – 0.02% 774
2015
Q2 		$729K Buy
119,000
+40,000
+51% +$310K 0.01% 906
2015
Q1 		$636K Buy
79,000
+8,614
+12% +$65K 0.01% 988
2014
Q4 		$356K Sell
70,386
-9,614
-12% -$47.5K 0.01% 1176
2014
Q3 		$415K Hold
80,000
– – 0.01% 1168
2014
Q2 		$622K Hold
80,000
– – 0.02% 985
2014
Q1 		$558K Buy
80,000
+40,000
+100% +$312K 0.02% 1022
2013
Q4 		$240K Sell
40,000
-29,400
-42% -$192K 0.01% 1263
2013
Q3 		$541K Buy
69,400
+15,000
+28% +$69.6K 0.02% 997
2013
Q2 		$207K Buy
+54,400
New +$223K 0.01% 1264

Other funds holding GNMX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $640M AUM 26.68% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Bridgeway Capital Management's GNMX Position: Q2 2019 in Review

Bridgeway Capital Management sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2019, closing a stake of 223,500 shares — an estimated $44K sold.

Bridgeway Capital Management first reported a position in GNMX in Q2 2013 and held it in 19 quarters. The position peaked at $1.04M in Q3 2016. 29 funds tracked by Wall St. Rank hold GNMX as of Q2 2019.

  • Bridgeway Capital Management reported no remaining Aevi Genomic Medicine Inc position as of Q2 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 223,500 Aevi Genomic Medicine Inc shares in Q2 2019, an estimated $44K.
  • Bridgeway Capital Management first reported a position in Aevi Genomic Medicine Inc in Q2 2013 and held it in 19 quarters.
  • Bridgeway Capital Management's Aevi Genomic Medicine Inc position peaked at $1.04M in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2019.

Based on Bridgeway Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.